Richard Marsden
Chief Executive Officer at SYNAIRGEN PLC
Net worth: 77 302 $ as of 2024-04-29
Network origin in Richard Marsden first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 20 | |
Respironics Ltd.
Respironics Ltd. Financial ConglomeratesFinance Respironics Ltd. develops and manufactures medical and healthcare products. Its products include Porta-Neb, Freeway Freedom, Sidestream, and Ventstream. The company was founded in 1977 and is headquartered in Bognor Regis, the United Kingdom.
5
| Subsidiary | Financial Conglomerates | 5 |
Southampton Asset Management Ltd.
Southampton Asset Management Ltd. Investment ManagersFinance Southampton Asset Management Ltd (SAM) is a venture capital firm, a subsidiary of University of Southampton Holdings Ltd. The firm is headquartered in Southampton, United Kingdom.
4
| Subsidiary | Investment Managers | 4 |
Synairgen Research Ltd.
Synairgen Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The company is based in Southampton, UK. Synairgen Research was founded in 2003.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Richard Marsden via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The University of Southampton | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
TranScrip Partners LLP
TranScrip Partners LLP Pharmaceuticals: MajorHealth Technology TranScrip Partners LLP is a consultancy provider for biotech and pharmaceutical companies. TranScrip Partners was founded in 2008 and is based in Wokingham, UK. The British company offers development and commercialization services to its clients. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SAVILLS PLC | Real Estate Development | Director/Board Member Director of Finance/CFO | |
Transcrip Ltd.
Transcrip Ltd. Pharmaceuticals: GenericHealth Technology Transcrip Ltd. is a consultancy provider for biotech and pharmaceutical companies. The company is based in Wokingham, UK and has subsidiaries in Ireland. The British company offers development and commercialization services to their clients. Transcrip was founded in 2008 by Marcin Mankowski and Felicity Jane Gabbay. | Pharmaceuticals: Generic | Founder Founder | |
University of Portsmouth | College/University | Masters Business Admin Corporate Officer/Principal | |
Karus Therapeutics Ltd.
Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
University of London | College/University | Doctorate Degree Graduate Degree | |
University of Cambridge | College/University | Graduate Degree | |
ILIKA PLC | Electrical Products | Chief Executive Officer | |
INSEAD | College/University | Masters Business Admin | |
ZOGENIX, INC. | Pharmaceuticals: Major | Founder | |
Rademacher Group Ltd. | President | ||
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director of Finance/CFO | |
RioTech Pharmaceuticals Ltd.
RioTech Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology RioTech Pharmaceuticals Ltd. develops novel therapeutic drugs for hepatitis C virus. The company was founded on Nov 5, 2001 by Graham Foster, Adrian V. S. Hill, Peter Karayiannis, Howard David Thomas and Mark R. Thursz and is headquartered in Horsham, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Hybrid BioSystems Ltd.
Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Hybrid is an Oxford Biotechnology Company focused on revolutionizing viral vaccines with its patented vaccine delivery technologies. Hybrid has an established and well equipped laboratory located at Cherwell Innovation Centre in Oxford shire, which houses both its corporate research facility and contract research services. Using a mixed product and platform business model it is developing its in-house lead products towards phase I/II proof of concept clinical trials as well as furthering its partnerships with leading pharmaceutical and biotechnology companies. Hybrid's experienced scientific and management team has reached this late stage of development through a highly efficient use of grant funding and revenues, together with minimal seed funding. With its unparalleled expertise in the field of viral steal thing technologies, The firm is also able to offer general and bespoke virology services, including high-quality adenovirus production and purification. Hybrid BioSystems uses iLabber electronic lab books for maximum IP protection and secure data storage. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
OrthoMimetics Ltd.
OrthoMimetics Ltd. Medical SpecialtiesHealth Technology Orthomimetics brings a new dimension to the treatment of joints damaged through sport or other orthopaedic trauma. Its heritage is a trans-Atlantic collaboration between two world-leading academic institutions, the University of Cambridge and the Massachusetts Institute of Technology (MIT), who have each contributed 30 years of experience to the repair of bone and soft tissues respectively. The harnessing of their expertise into viable therapeutic medical products is the foundation of Orthomimetics. | Medical Specialties | Corporate Officer/Principal | |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO | |
Chronos Therapeutics Ltd.
Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
BACANORA LITHIUM | Chemicals: Agricultural | Director/Board Member | |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Society of Pharmaceutical Medicine | Founder | ||
OXFORD BIOMEDICA PLC | Biotechnology | Chairman | |
DESTINY PHARMA PLC | Pharmaceuticals: Major | Chairman | |
CAMBRIDGE COGNITION HOLDINGS PLC | Packaged Software | Director/Board Member | |
The Royal College of Physicians | College/University | Corporate Officer/Principal | |
The University of Manchester | College/University | Undergraduate Degree | |
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
University of Lancaster | College/University | Graduate Degree | |
SOLGOLD PLC | Precious Metals | Director of Finance/CFO | |
Mazars LLP
Mazars LLP Miscellaneous Commercial ServicesCommercial Services Mazars LLP operates as an accounting firm. It specializes in audit, accountancy, advisory, tax, and legal services. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor |
Statistics
International
United Kingdom | 38 |
United States | 4 |
France | 2 |
Israel | 2 |
Sectoral
Health Technology | 19 |
Consumer Services | 9 |
Commercial Services | 8 |
Finance | 4 |
Producer Manufacturing | 2 |
Operational
Director/Board Member | 108 |
Corporate Officer/Principal | 57 |
Director of Finance/CFO | 19 |
Chairman | 16 |
Corporate Secretary | 14 |
Most connected contacts
Insiders | |
---|---|
Stephen Holgate | 24 |
Nick Rodgers | 18 |
Jonathan Rigby | 16 |
Joseph Colliver | 16 |
Simon Holden | 16 |
Simon Shaw | 14 |
Iain Peter Murray Buchanan | 13 |
Rupert Sebag-Montefiore | 12 |
Felicity Gabbay | 11 |
Theodora Caroline Harold | 10 |
David Campbell | 9 |
Paul Hugh Anthony Clegg | 8 |
Ann V. Hacker | 8 |
Graeme Purdy | 6 |
John Ward | 6 |
- Stock Market
- Insiders
- Richard Marsden
- Company connections